4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0001209191-22-011077
Chief Executive Officer gave up 18,734 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Barrow Robert Chief Executive Officer | 2022-02-15 | Shares withheld for taxes | −18,734 | $1.35 | $25,291 | 2,225,979 | D |
Loading xslF345X03/doc4.xml…